key: cord-1051451-v9y1iw3o
authors: Carossino, Mariano; Montanaro, Paige; O’Connell, Aoife; Kenney, Devin; Gertje, Hans; Grosz, Kyle A.; Ericsson, Maria; Huber, Bertrand R; Kurnick, Susanna A.; Subramaniam, Saravanan; Kirkland, Thomas A.; Walker, Joel R.; Francis, Kevin P.; Klose, Alexander D.; Paragas, Neal; Bosmann, Markus; Saeed, Mohsan; Balasuriya, Udeni B. R.; Douam, Florian; Crossland, Nicholas A.
title: Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression
date: 2021-09-23
journal: bioRxiv
DOI: 10.1101/2021.01.13.425144
sha: f18affc0f54a56f4a118f5d60148fd4bc519ea49
doc_id: 1051451
cord_uid: v9y1iw3o

Animal models recapitulating distinctive features of severe COVID-19 are critical to enhance our understanding of SARS-CoV-2 pathogenesis. Transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) under the cytokeratin 18 promoter (K18-hACE2) represent a lethal model of SARS-CoV-2 infection. The precise mechanisms of lethality in this mouse model remain unclear. Here, we evaluated the spatiotemporal dynamics of SARS-CoV-2 infection for up to 14 days post-infection. Despite infection and moderate pneumonia, rapid clinical decline or death of mice was invariably associated with viral neuroinvasion and direct neuronal injury (including brain and spinal neurons). Neuroinvasion was observed as early as 4 dpi, with virus initially restricted to the olfactory bulb supporting axonal transport via the olfactory neuroepithelium as the earliest portal of entry. No evidence of viremia was detected suggesting neuroinvasion occurs independently of entry across the blood brain barrier. SARS-CoV-2 tropism was not restricted to ACE2-expressing cells (e.g., AT1 pneumocytes), and some ACE2-positive lineages were not associated with the presence of viral antigen (e.g., bronchiolar epithelium and brain capillaries). Detectable ACE2 expression was not observed in neurons, supporting overexpression of ACE2 in the nasal passages and neuroepithelium as more likely determinants of neuroinvasion in the K18-hACE2 model. Although our work incites caution in the utility of the K18-hACE2 model to study global aspects of SARS-CoV-2 pathogenesis, it underscores this model as a unique platform for exploring the mechanisms of SARS-CoV-2 neuropathogenesis that may have clinical relevance acknowledging the growing body of evidence that suggests COVID-19 may result in long-standing neurologic consequences. IMPORTANCE COVID-19 is predominantly a respiratory disease caused by SARS-CoV-2 that has infected more than 191 million people with over 4 million fatalities (2021-07-20). The development of animal models recapitulating distinctive features of severe COVID-19 is critical to enhancing our understanding of SARS-CoV-2 pathogenesis and in the evaluation of vaccine and therapeutic efficacy. Transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2) under the cytokeratin 18 promoter (K18-hACE2) represent a lethal model of SARS-CoV-2 infection. Here, we show lethality of this model is invariably associated with viral neuroinvasion linked with viral replication and assembly. Importantly, pneumonia albeit invariably present was generally moderate with the absence of culturable infectious virus at peak neuroinvasion. The dynamics of viral neuroinvasion and pneumonia were only partially dependent on hACE2. Overall, this study provides an in-depth sequential characterization of the K18-hACE2 model following SARS-CoV-2 infection, highlighting its significance to further study the mechanisms of SARS-CoV-2 neuropathogenesis.

and its role in the clinical decline of SARS-CoV-2 infected K18-hACE2 mice is becoming 126 more readily acknowledged (19, 40, 41) . 127 Under K18 regulation, the expression of hACE2 is reported to be limited mainly to airway 128 epithelial cells and enterocytes lining the colonic mucosa, to a lower degree within kidney, 129 liver, spleen, and small intestine, and to a relatively minor level of expression in the brain 130 (36). However, the cellular distribution of ACE2, and particularly hACE2, in tissues of K18-131 hACE2 mice remains largely undetermined. We hypothesized that the nature, severity, 132 and outcome of disease in K18-hACE2 mouse model is not solely dictated by the 133 expression and tissue distribution of hACE2 and that increased lethality in this model is 134 ultimately related to neuroinvasion, in part driven by regional ACE2 overexpression in the 135 nasal passages promoting retrograde axonal transport through the olfactory nerve. To 136 investigate this hypothesis, we undertook a comprehensive spatiotemporal analysis of 137 histologic and ultrastructural changes, cellular distribution of viral protein and RNA, viral 138 loads, and antibody titers, along with a detailed analysis of the distribution of hACE2 139 mRNA, ACE2 protein, and its correlation with SARS-CoV-2 tropism as it pertains to this 140 model.

Although SARS-CoV-2 protein and RNA were detected in ACE2-expressing cells such as 142 olfactory neuroepithelium (ONE) and alveolar type 2 (AT2) cells, we found that SARS- detection of abundant viral protein, RNA, and virus particle assembly. Although 151 pneumonia was uniformly observed and peaks at 7 dpi, it was of moderate severity with 152 declining viral loads compared to that of the brain. We found that several histologic 153 hallmarks of severe COVID-19 were lacking in this model, (i.e., lack of diffuse alveolar 154 damage and microthrombi), suggesting pneumonia plays a contributing role rather than 155 the primary determinant of lethality in this model. Interestingly, the absence of detectable 156 ACE2 expression in neurons suggested that viral neuroinvasion is a mechanism partially 157 independent of ACE2. 158 Altogether, this study expands the current knowledge on the K18-hACE2 murine model 159 to study severe COVID-19. Our findings will help refine utilization of this model for 

K18-hACE2 mice inoculated intranasally with SARS-CoV-2 (1x10 6 plaque-forming units 167 [PFU]; n=35 [n=19 male and n=16 female) began losing weight as early as 4 days post-168 infection (dpi) irrespective of sex, with maximum weight loss occurring at 6-7 dpi (18.4% 169  6.8% in male mice, 21.4%  1.8% in female, and combined 19.7%  5.2%; Fig. 1A ). 170 Trends in weight loss paralleled increasing clinical scores and declines in core body 171 temperature, with the latter two precipitously increasing or decreasing respectively near 172 the time of death (Fig. 1B, C) . SARS-CoV-2-infected K18-hACE2 mice exhibited 173 neurological signs starting 6 dpi, characterized by profound stupor, tremors, 174 proprioceptive defects, and abnormal gait, with most animals euthanized or found dead 175 in their cage at 6 and 7 dpi (~94%; 33/35 [Fig. 1D] ). At the time of death (6-7 dpi), the 176 median clinical score was 3 (interquartile range = 1) and the mean body temperature was 177 30.9  3.0 °C. Two male mice survived to the end of the 14-day observation period and 178 did not display hypothermia during the course of the observation period, a feature that 179 was consistently observed in animals that succumbed to disease or met euthanasia 180 criteria.

Peak of lethality was associated with significant increases in viral loads (viral RNA and 182 infectious virus particles) in the brain of the K18-hACE2 mice (Fig. 1E, F) , as previously 183 reported (19, 38, 41) . In the lung, viral RNA copies were detectable at the earliest 184 experimental timepoint (2 dpi) and remained stable over time, consistently within the 185 value range reported in previous studies (30) . While viral RNA remained high, viral titers 186 however gradually declined over time, with no infectious virus recovered by 7 dpi (Fig. 187 1E-F). Although the absence of recoverable infectious virus in the lungs at 7 dpi was 188 unexpected, this sharp decline mirrors published work that illustrated a 100-fold decline 189 in PFUs at 7 dpi compared to 4 dpi (30). In contrast, viral RNA and infectious particles in 190 the brain were low to undetectable at 4 dpi, but dramatically increased at 7 dpi representing the highest mean viral RNA load and infectious virus particles during the 192 study. A small amount of viral RNA was detected in the serum (Fig.1G); however, 193 incubation of SARS-CoV-2 permissive cell lines with serum samples did not result in any 194 6 detectable productive infection in vitro, confirming an absence of viremia in intranasally-195 inoculated K18-hACE2 mice (Fig. 1H) . Altogether, our data illustrate that lethality was 196 associated with increasing viral RNA loads and infectious virus particles in the brain, 197 which were simultaneously declining in the lung. analyzed the anterior/rostral nasal cavity and olfactory neuroepithelium (Fig. 205 2G-L) for disease-associated lesions. To do so, we performed a thorough sequential 206 histologic analysis combined with immunohistochemistry (IHC) and RNAscope® in situ 207 hybridization (42) to determine the cellular localization and abundance of SARS-CoV-2 208 protein and RNA, using an anti-spike monoclonal antibody and an 209 respectively.

At 2 dpi, the anterior/rostral nasal cavity was characterized by mild, multifocal neutrophilic 211 inflammation (rhinitis) with segmental degeneration and necrosis of transitional and 212 respiratory epithelium (Fig. 2B ), which colocalized with intracytoplasmic SARS-CoV-2 213 protein and RNA (Fig. 2E) . Adjacent nasal passages were partially filled with small 214 amounts of cellular debris, degenerate neutrophils, and small numbers of erythrocytes.

The lamina propria underlying affected areas was infiltrated by low to mild numbers of 216 neutrophils and fewer lymphocytes (Fig. 2B) . At 4 dpi, epithelial degeneration and 217 7 necrosis in the rostral and intermediate turbinates was no longer observed, replaced by 218 mild residual lymphocytic rhinitis and rare neutrophils within the lamina propria (Fig. 2C) , 219 and absence of exudate within nasal passages. SARS-CoV-2 protein and RNA were less 220 commonly observed and restricted to rare positive cells in the respiratory epithelium (Fig. 221 2F and Table 1 and Table S1 ). By 7 dpi, the anterior/rostral nasal cavity was histologically 222 within normal limits and no SARS-CoV-2 protein or RNA were detectable (Fig. 2C, F and 223 Table 1 and Table S1 ).

The posterior nasal cavity, olfactory neuroepithelium (ONE) , displayed mild 225 segmental degeneration and necrosis at 2 dpi, which colocalized with abundant SARS-

CoV-2 protein and RNA (Fig. 2K and Table 1 and Table S1 ). By 4 dpi, histopathologic 227 lesions in the ONE had resolved, but rare SARS-CoV-2 protein and RNA were observed 228 both at 4 and 7 dpi (Fig. 2L and Table 1 ). No SARS-CoV-2 protein or RNA were detected 229 in the ONE by 14 dpi (Table 1 and Table S1 ). 230 231 SARS-CoV-2 induces moderate interstitial pneumonia in K18-hACE2 mice.

In the lower respiratory tract, histologic alterations in the pulmonary parenchyma mainly 233 involved the alveoli, interstitium and perivascular compartment . Overall, 234 pathologic alterations in the lungs were characterized by moderate progressive 235 lymphohistiocytic and neutrophilic interstitial pneumonia that peaked at 7 dpi (Fig. 3G, H) . 236 We quantitatively analyzed the total % of pneumonia using a machine learning classifier 237 to differentiate normal vs. pneumonic lung tissue. Peak disease was confirmed to occur 238 at 7 dpi, with a mean of ~10% of total lung area affected, with one outlier of ~40% of total 239 lung area, suggesting that more severe disease is possible, albeit uncommon (Fig. 3K) . Of note, data from our 2 dpi animals were excluded from tissue classification analysis as 241 lungs were sub-optimally insufflated and the classier algorithm falsely labeled areas of 242 atelectasis as pneumonia. Pneumonia was interpreted to be minimal at this timepoint and, 243 thus, considered negligible.

At 2 dpi, minimal perivascular and peribronchiolar inflammation, consisting primarily of 245 lymphocytes and histiocytes, and occasional perivascular edema were observed (Fig. 246 3C). Pulmonary vessels were frequently reactive and lined by a plump endothelium with 247 marginating leukocytes (Fig. 3D ). SARS-CoV-2 protein and RNA were 248 observed in proximity to areas of interstitial pneumonia and localized within the cytoplasm 249 of alveolar type (AT) 1 (squamous epithelium) and fewer AT2 cells (cuboidal epithelium) 250 (Fig. 4B, G) .

At 4 dpi, peak in viral protein and RNA abundance were observed (correlating with the 252 highest viral titer and RNA load as determined by RT-qPCR and plaque assays) (Fig 4C, 253 H) along with increasing lymphohistiocytic and neutrophilic infiltrate (Figs. 3E, F). SARS-

CoV-2 cellular tropism did not differ from that described at 2 dpi, but SARS-CoV-2 protein 255 and RNA were more abundant and routinely observed in histologically normal 256 pneumocytes (Fig 4C, H) .

At 7 dpi, lymphohistiocytic and neutrophilic interstitial pneumonia peaked in severity, 258 which on average was moderate to regionally severe, affecting ~10-40% of the 259 parenchyma (Fig. 3G, H, K) . Additional unique findings at 7dpi included, rare alveolar 260 septal necrosis, mild proliferation of AT2 cells, and sporadic regional pulmonary edema 261 (Fig. 3G, H) . SARS-CoV-2 protein and RNA were occasionally still abundant in several 262 animals, but predominated in histologically normal parenchyma, with minimal to rare 263 9 detection in areas of prominent inflammation (Fig. 4D, I and Table 1, and Table S1 ).

Taken together, this suggested progressive resolution of viral infection by the host 265 consistent with declining viral loads and absence of culturable infectious virus at this 266 timepoint (Fig. 1E, F) .

In the two survivors euthanized at 14 dpi, persistent mild to moderate lymphohistiocytic 268 interstitial pneumonia was observed, with formation of sporadic lymphoid aggregates and 269 mild persistence of AT2 hyperplasia (Fig. 3I, J) . SARS-CoV-2 protein or RNA were no 270 longer detectable at 14 dpi (Fig 4E, J) .

Of note, no evidence of SARS-CoV-2 infection was observed in bronchiolar epithelium 272 and pulmonary vasculature at any time during the study (Figs. 3 and 4, and Table 1, and   273   Table S1 ). Similarly, hyaline membranes, vascular thrombosis, and syncytial cells were Pulmonary SARS-CoV-2 replication occurs exclusively in AT1 and AT2 cells. 288 Subsequently, we aimed to further investigate SARS-CoV-2 tropism in the lower 289 respiratory tract of K18-hACE2 mice. We first performed qualitative multiplex IHC to probe infected K18-hACE2 mice . SARS-CoV-2 S immunoreactivity peaked between 310 4-7 dpi (Fig. 6A) , supporting a positive correlation between viral infection and the 311 progressive inflammatory cell infiltrate, but was not statistically significant across groups. 312 We attribute this finding to our low sample size for quantitative whole slide analysis, (necrosis) (Fig. 9D, E) . Although viral assembly and/or particles were not observed in 390 microglia or astrocytes, quantitative immunohistochemical analysis supports reactive 391 microgliosis and astrogliosis that is temporally linked with peak neuroinvasion, suggesting 392 that activation of these cells contributes to neuronal injury either through direct neurotoxic 393 and/or loss of normal homeostatic neurotrophic mechanisms.

Considering the severe bladder distention noted at necropsy and proprioceptive deficits 395 observed clinically, we examined the cervicothoracic and lumbosacral segments of the 396 spinal cord. In 9/11 animals that died or were euthanized due to terminal disease, similar 397 histologic findings were observed as those described in the brain, albeit with milder gliosis 398 and lymphocytic perivascular cuffing (Fig. 10A ). We also observed mild-to-moderate 399 detection of viral protein in the spinal cord that predominated within neurons of the 400 cervicothoracic segments (Fig. 10B , and Table 1 and Table S1 ). Finally, Luxol Fast Blue 401 15 was utilized to visualize the integrity of myelin following SARS-CoV-2 invasion in the brain 402 and spinal cord at 7 dpi, with no evidence of demyelination noted (Fig. 10C ).

Taken together, our data illustrate that SARS-CoV-2 infection of K18-hACE2 results in To further explore the mechanism driving lethal SARS-CoV-2 infection in K18-hACE2 418 mice, we first investigated the tissue and cellular distribution of the ACE2 receptor in both 419 C57BL/6J and K18-hACE2 mice by IHC (Fig. 11A -L) using a cross-reactive anti-ACE2 420 antibody (cross-reactive to hACE2 and mACE2) (Table S2 ). In the lower respiratory tract 421 (lungs), ACE2 was ubiquitously expressed along the apical membrane of bronchiolar 422 epithelium and, less commonly, in rare and scattered AT2 pneumocytes . No 423 ACE2 expression was found in AT1 pneumocytes. No evident differences in the 424 distribution and abundance of ACE2 expression were identified between uninfected 425 C57BL/6J, sham-inoculated K18-hACE2, and terminal (7 dpi) K18-hACE2 mice 426 inoculated with SARS-CoV-2. 427 We therefore aimed at analyzing expression and distribution of hACE2 mRNA using 428 RNAscope® ISH (Fig.12) . Although no expression of hACE2 mRNA was detected in the 429 lungs of non-transgenic C57BL/6J mice (Fig. 12A) , expression of hACE2 mRNA was 430 detectable, but of low expression in the lungs of K18-hACE2 mice, and mostly involved 431 bronchiolar epithelial cells with sporadic expression in AT2 pneumocytes (Fig. 12B, C) .

These findings therefore suggest that hACE2 expression might not be the sole host factor 433 determinant of susceptibility to SARS-CoV-2. This is clearly exemplified by the following: 434 1) certain cell types that, while expressing hACE2, were non-permissive to SARS-CoV-2 435 infection throughout the experiment (i.e. bronchiolar epithelial cells); and 2) the near 436 diffuse infection of AT1 cells by 4 dpi despite absent expression of hACE2 in these cells.

Altogether, these observations then support evidence for an ACE2-independent viral 438 entry mechanism playing a major role in the pulmonary dissemination of K18-hACE2 439 mice.

In contrast to the lung, ACE2 protein was clearly overexpressed in the nasal cavity of CoV-2-infected K18-hACE mice . For the olfactory bulb, olfactory 448 neuroepithelium and respiratory epithelium of rostral turbinates, estimation of hACE2 449 abundance and distribution could not be accurately assessed since the decalcification 450 procedure is believed to have had a significant impact in the quality of cellular mRNA as 451 demonstrated by the low detection of the housekeeping mRNA, Ppib (data not shown).

In the brain of both C57BL/6J and K18-hACE2 mice, ACE2 protein was observed in the 

To date, the precise mechanism(s) enabling neuroinvasion in the K18-hACE2 model is 566 poorly understood (11, 13, 15, 16, 52) . Here, we determined that K18-hACE2 transgenic 567 mice show a significant upregulation in the expression of ACE2 in the nasal cavity 568 compared to wild-type C57BL/6J mice, in which ACE2 expression is undetectable by IHC.

This difference between K18-hACE2 and C57BL/6J mice is clearly attributed to the overexpression at the interface of the ONE and neuronal synapses may be sufficient to 586 rationalize the severe neuroinvasion observed in this model.

Infection of brain organoids has been shown to be inhibited using anti-ACE2 antibodies 588 (19). However, brain organoids do not recapitulate the complexity of the entire CNS, and 589 axonal transport of viral particles into the CNS can hardly be modeled in vitro. Altogether, 590 this suggests that while ACE2 is assuredly an important mediator of CNS neuroinvasion, (Table 2) . Categories evaluated included body weight, 735 general appearance, responsiveness, respiration, and neurological signs for a maximum 736 score of 5. Animals were considered moribund and humanely euthanized in the event of 737 the following: a score of 4 or greater for 2 consecutive observation periods, weight loss 738 greater than or equal to 20%, severe respiratory distress, or lack of responsiveness.

Clinical signs and body temperature were recorded once per day for the duration of the 740 study. For design of the survival curve, animals euthanized on a given day were counted 741 dead the day after. Animals found dead in cage were counted dead on the same day. Samples were centrifuged at 17,000 X g (13,000 rpm) for 10 minutes and supernatant 761 was transferred to a new 1.5 ml tube. Viral RNA isolation was performed using a Qiagen Corrales, NM). Slides were manually annotated to include only the brain and/or lung classifier was run on whole lung images to determine the percentage of pneumonia.

Quantitative outputs are given as total classified area (mm 2 ), normal lung area (mm 2 ), 909 and pneumonia area (mm 2 ). We divided pneumonic area by total classified area to 910 generate a percentage of pneumonia for statistical analysis. 

The proximal 970 origin of SARS-CoV-2

The species Severe acute respiratory syndrome-related coronavirus: 973 classifying 2019-nCoV and naming it SARS-CoV-2

A novel coronavirus outbreak of 975 global health concern

Clinical Characteristics of Covid-19 in New York City

Investigators 987 IVYN, Team CC-R, Investigators IVYN. 2020. Symptom Duration and Risk Factors 988 for Delayed Return to Usual Health Among Outpatients with COVID

Multistate Health Care Systems Network -United States

Long-Term Respiratory and Neurological 992 Sequelae of COVID-19

Obesity study g. 2020. High 995 Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus

SARS-CoV-2) Requiring Invasive Mechanical Ventilation

Obesity and Mortality Among Patients Diagnosed With COVID-1001 19: Results From an Integrated Health Care Organization

Preliminary Estimates of the Prevalence of Selected 1004

Underlying Health Conditions Among Patients with Coronavirus Disease 2019 -1005 United States

Neuromechanisms of SARS-CoV-2: A Review

Loss of smell in patients with COVID-19: MRI data 1013 reveal a transient edema of the olfactory clefts

Neurological associations of COVID-19

Microvascular Injury in the Brains of Patients 1020 with Covid-19

Evidence of central nervous 1022 system infection and neuroinvasive routes, as well as neurological involvement, in 1023 the lethality of SARS-CoV-2 infection

Anosmia and loss of smell in the 1028 era of covid-19

Olfactory 1036 transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in 1037 individuals with COVID-19

Renier 1043 N, Bilguvar K, Iwasaki A. 2021. Neuroinvasion of SARS-CoV-2 in human and 1044 mouse brain

Animal and translational models of SARS-CoV-2 infection and 1050 COVID-19

A Critical Needs Assessment for 1052 Research in Companion Animals and Livestock Following the Pandemic of 1053 COVID-19 in Humans. Vector Borne Zoonotic Dis

Animal models for COVID-19

CoV-2 infection, disease and transmission in domestic cats

Syrian hamsters as a small animal model for SARS-CoV-2 infection and 1074 countermeasure development

Susceptibility of swine cells and domestic 1078 pigs to SARS-CoV-2

Comparative pathogenesis of COVID-19, MERS, and SARS 1085 in a nonhuman primate model

Susceptibility of ferrets, cats, dogs, and other domesticated animals 1089 to SARS-coronavirus 2

Replication, pathogenicity, and transmission of SARS-CoV-2 in minks. National 1093 Science Review

Pathogenesis and 1096 transmission of SARS-CoV-2 in golden hamsters

SARS-CoV-2 infection of human ACE2-transgenic mice 1100 causes severe lung inflammation and impaired function

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked 1105 by a Clinically Proven Protease Inhibitor

The SARS-CoV-2 Spike protein has a broad tropism 1110 for mammalian ACE2 proteins

Broad 1114 host range of SARS-CoV-2 predicted by comparative and structural analysis of 1115 ACE2 in vertebrates

A mouse-1119 adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Yang 1123 XL, Shi ZL. 2020. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing 1124

Lethal infection of K18-hACE2 mice infected with severe acute respiratory 1128 syndrome coronavirus

Comparison of transgenic and 1131 adenovirus hACE2 mouse models for SARS-CoV-2 infection

COVID-19 1135 treatments and pathogenesis including anosmia in K18-hACE2 mice

Angiotensin-1139 converting enzyme 2 is a functional receptor for the SARS coronavirus

Human angiotensin-converting 1144 enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal 1145 respiratory disease

Neuroinvasion and Encephalitis Following Intranasal 1148 Inoculation of SARS-CoV-2 in K18-hACE2 Mice

Detection of SARS-CoV-2 by RNAscope((R)) in situ 1151 hybridization and immunohistochemistry techniques

CoV-2 Associated with Fatal Coronavirus Disease, United States

Acute 1161

Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but 1162

Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques

Live imaging of SARS-1174

CoV-2 infection in mice reveals neutralizing antibodies require Fc function for 1175 optimal efficacy

Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection

CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice

K18-hACE2 mice develop 1191 respiratory disease resembling severe

A Mouse Model of SARS-1196

CoV-2 Infection and Pathogenesis

Autopsy findings in COVID-19-related deaths: a literature review

olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-1204 2 in golden Syrian hamsters

Age-Dependent Progression 1207 of SARS-CoV-2 Infection in Syrian Hamsters

Defining the Syrian hamster as a highly susceptible 1211 preclinical model for SARS-CoV-2 infection

Neuropilin-1 facilitates SARS-CoV-2 1218 cell entry and infectivity

SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel 1224 mediator

Elevated ACE-2 expression in the olfactory neuroepithelium: implications for 1227 anosmia and upper respiratory SARS-CoV-2 entry and replication

In vivo 1234 monoclonal antibody efficacy against SARS-CoV-2 variant strains

A novel highly potent inhibitor of TMPRSS2-like proteases 1240 blocks SARS-CoV-2 variants of concern and is broadly protective against infection 1241 and mortality in mice

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting 1247 the host protein eEF1A

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and 1251 screening of anti-infective drugs for COVID-19

Detection of 2019 1256 novel coronavirus (2019-nCoV) by real-time RT-PCR

Body weight 1261 (A), clinical signs (B), temperature (C), and survival (D) were monitored daily in sham/PBS 1262 animals (black

Viral loads 1264 (genome copy numbers/mg) or infectious virus particles (PFU/mg of tissue) were 1265 monitored in the lung and brain (E-F)

The limit of detection is shown with a dashed line. n=3 (sham/PBS, n=19 1268 (male), n=16 (female)

0001. For A-D, blue and green asterisks compare sham group vs. male group, 1270 and sham group vs. female group respectively. NA, non-applicable statistical test due 1271 extensive animal death at 6 dpi and

Temporal analysis of SARS-CoV-2 infection in the nasal cavity of K18-hACE2

Histological changes, and viral protein (brown) and RNA (red) distribution and 1274 abundance were assessed in non-infected (mock: A, D, G, J) and infected mice at 2 (B

At 4 dpi, only sporadically infected cells were noted in the 1280 epithelium lining the nasal turbinates and ONE (F and L, arrow and insets) in the absence 1281 of histologic lesions (C and I)

Red (viral RNA), 200X total magnification. Bar = 100 μm

Temporal analysis of SARS-CoV-2 infection in the lungs of K18-hACE2 mice

Subgross 1286 histological images of the lungs and corresponding pneumonia classifiers for each 1287 timepoint are depicted in panel K (green = normal; yellow = pneumonia). Mild to moderate 1288 interstitial pneumonia was evident starting at 2 dpi with frequently reactive blood vessels 1289 (D, arrow)

Residual mild pneumonia was observed in the rare animals that survived to 14 dpi, with 1291 rare sporadic lymphoid aggregates (J-arrows)

Temporal analysis of SARS-CoV-2 RNA and protein distribution in the lungs 1295 of K18-hACE2 mice. Presence of viral RNA (A-E) and Spike protein (F-J) was assessed 1296 by ISH and IHC in non-infected (mock: A, F) and infected lung tissues from K18-hACE2 1297 mice at 2

Peak viral RNA and protein occurred at 4 dpi (C,H)

No viral RNA or protein were detected at 14 dpi (E, J)

SARS-CoV-2 tropism following intranasal inoculation in K18-hACE2

AT2, red) cells (B and C, arrowheads, and arrows, 1305 respectively) but not for CD31 + endothelial cells. B and C represent magnification of inset 1306 1 and 2 from A, respectively. (D-F) 6 dpi, virus particles (VPs) were bound by double 1307 membrane vesicles (DMVs) in AT1 (E) and AT2 (F) cells. AT1 contained abundant 1308 caveolae. Another unique feature observed in AT1 cells was the presence of cubic 1309 membranes (CM)

represent magnification of inset 1 and 2 from D, respectively. (G, H) Viral particles 1311 were not identified in ciliated or non-ciliated club bronchiolar epithelium. H represents an 1312 inset magnification of G. Multiplex fluorescent IHC, 100x (A; bar= 100 μm) and

μm (C). A, alveolar lumen; BM, basement membrane; C, capillary; Cav, caveolae; Ci

club epithelium; CM, cubic membranes; DMVs, double-membrane 1316 vesicles; END, endothelium; J; cell-cell junction; VPs

Temporal immunoprofiling of the pulmonary host inflammatory response to 1318

A-H) Quantification and 4-plex fluorescent IHC targeting SARS-CoV-2

H) infiltration in the lung of sham/PBS mice and in inoculated mice (2, 4, 7 and 14 dpi)

macrophages (red) increased significantly peaking at 7 dpi (B, G), along with a lower 1323 infiltration of CD8+ T lymphocytes-magenta that peaked between 4-7 dpi

CD19+ B cells arranged in 1325 clusters were only evident in the two survivors euthanized at 14 dpi (D, H). Insets depict 1326 immune cell phenotyping outputs

Multiplex fluorescent IHC (E-H): 100X and 400X (insets) total magnification

Neutralizing activity of serum isolated from a naïve/non-infected K18-hACE2 (purple) 1329 and from the two 14 dpi survivors at 14 dpi (survivor 1 and 2, red and black respectively)

RBD, blue) was used as a positive 1331 control. Serum was serially diluted by 2-fold. One-way ANOVA. **p≤0

Temporal neuronal damage in K18-hACE2 mice following intranasal 1333 inoculation with SARS-CoV-2. Histologic changes in the cerebrum

SARS-CoV-2 protein (brown) was evident as early as 1337 4 dpi (I, arrow), but no histologic changes were noted until 7 dpi (J-K)

Similar changes were evident in the olfactory bulb, with occasional perivascular 1341 cuffs/gliosis (K, arrowhead) and abundant viral protein (L, arrows)

Sagittal sections 1346 of the head of non-infected (mock, top panel) and infected (4 and 7 dpi, middle and bottom 1347 panel respectively) were analyzed for viral protein and RNA distribution

At 7 dpi (bottom panel), SARS-CoV-2 protein was widespread along 1351 the mitral layer of the olfactory bulb (1) and throughout the central nervous system

RNA in inset) with exception of the cerebellum. EPL, external plexiform 1353 layer

GCL, granular cell layer

On the right of each panel, pictures labelled 1 and 2 are 266X total 1356 magnification insets represented by the hashed squares labeled in the lower (7.5X) 1357 magnification images. (B) Representative three-dimensional profile view (right side) of a 1358 K18-hACE2 mouse following inoculation with a rSARS

NanoLuc bioluminescent signal was detected and quantified at 6 dpi following 1360 fluorofurimazine injection (Sub-cutaneous) using the InVivoPLOT (InVivoAx) system and 1361 an IVIS Spectrum (PerkinElmer) optical imaging instrument. Location of the lungs and 1362 brain are indicated

SARS-CoV-2 replication and assembly of virus particles in hippocampal 1364 neurons and glial response. (A-C) Quantification (A) of 3-plex fluorescent IHC

targeting SARS-CoV-2 Spike, astrocyte (GFAP) and Iba-1+ microglial infiltration in the

brain of sham/PBS mice and in inoculated mice (2, 4, 7 and 14 dpi) . The amount of viral 1367 protein rapidly and markedly increases by 7 dpi, along with an intense astrocytic and